We are live on
!
Find out more
RBFC
Roman Butler Fullerton & Co Portfolio holdings
AUM
$364M
1-Year Est. Return
27.64%
This Fund
S&P 500
This Quarter
Est. Return
+12.95%
1 Year Est. Return
+27.64%
3 Year Est. Return
+108.65%
5 Year Est. Return
+154.92%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$16.5M
(+11%)
Cap. Flow
+$390K
Cap. Flow
% of AUM
0.23%
Top 10 Holdings %
Top 10 Hldgs %
27.92%
Holding
180
New
27
Increased
90
Reduced
38
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entegris
ENTG
|
+$738K |
| 2 |
IPHI
INPHI CORPORATION
IPHI
|
+$535K |
| 3 |
Apple
AAPL
|
+$525K |
| 4 |
DQ
Daqo New Energy
DQ
|
+$463K |
| 5 |
REGI
Renewable Energy Group, Inc.
REGI
|
+$435K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.09M |
| 2 |
AT&T
T
|
+$1.09M |
| 3 |
Cigna
CI
|
+$999K |
| 4 |
iShares Morningstar Growth ETF
ILCG
|
+$887K |
| 5 |
Alibaba
BABA
|
+$830K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.03% |
| 2 | Communication Services | 8.61% |
| 3 | Financials | 8.25% |
| 4 | Consumer Staples | 7.98% |
| 5 | Healthcare | 7.55% |
Similar funds
EW
ACM
RGC
DCP
SWA
VIA
RC
OAJ
Roman Butler Fullerton & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Roman Butler Fullerton & Co held 180 positions worth $169M, up 11% from $153M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Roman Butler Fullerton & Co's Q4 2020 filing shows 27 new, 90 increased, 38 reduced and 10 closed positions. Its largest new stake was Entegris: 8,447 shares worth $812K. The largest sale was Vertex Pharmaceuticals, an estimated $1.09M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.
- Roman Butler Fullerton & Co's largest Q4 2020 buy was Entegris: 8,447 shares worth $812K.
- Roman Butler Fullerton & Co added most to Apple in Q4 2020, an estimated $525K increase.
- Roman Butler Fullerton & Co's biggest Q4 2020 reduction was AT&T, cutting an estimated $1.09M.
- Roman Butler Fullerton & Co fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $1.09M.
- Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $169M portfolio in Q4 2020.
- Roman Butler Fullerton & Co opened 27 new positions and closed 10 in Q4 2020.
- Roman Butler Fullerton & Co's portfolio value rose 11% quarter-over-quarter to $169M.
Based on Roman Butler Fullerton & Co's 13F filing for Q4 2020, filed 1 Feb 2021.